In the present work, we made one crucial step forward by using a mouse model for hyperbilirubinemia showing early neonatal lethality36, 37 and treating mutant pups with repeated HSA infusions since birth, without the application of PT. The gene discussed is ALB; the disease is Hyperbilirubinemia.